Business
Here’s why the Rhythm (ASX:RHY) share price hit an all-time high today
Shares in Rhythm Biosciences Ltd (ASX: RHY) are soaring higher during early afternoon trade. This comes after the company announced it has added two extra clinical trial sites for its ColoSTAT study.
Rhythm’s ColoSTAT is an experimental test-kit that is being trialled as a low-cost, easy-to-use blood test to detect colorectal cancer.
At the time of writing, the Rhythm share price is advancing 7.5% to $1.43 after reaching an-all time high of $1.47 around midday. In comparison, the All Ordinaries Index (ASX: XAO) is also moving higher, up 1.1% to 7,014 points.
Why is the Rhythm share price climbing?
Rhythm advised today that the Concord Repatriation General Hospital in Sydney’s inner west will participate in the ColoSTAT clinical…
-
Business23 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News18 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Business19 hours agoUp 105% in a year, are Pro Medicus shares still a good buy today?
-
Business17 hours agoEverything you need to know about the Coles dividend